Related references
Note: Only part of the references are listed.Proteomic signature of the Dravet syndrome in the genetic Scn1a-A1783V mouse model
Nina Miljanovic et al.
NEUROBIOLOGY OF DISEASE (2021)
Interneuron Desynchronization Precedes Seizures in a Mouse Model of Dravet Syndrome
Conny H. Tran et al.
JOURNAL OF NEUROSCIENCE (2020)
Bile Acid Signaling in Neurodegenerative and Neurological Disorders
Stephanie M. Grant et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Disruption of the sodium-dependent citrate transporter SLC13A5 in mice causes alterations in brain citrate levels and neuronal network excitability in the hippocampus
Christine Henke et al.
NEUROBIOLOGY OF DISEASE (2020)
Efficacy of the ketogenic diet in patients with Dravet syndrome: A meta-analysis
Yan-Qiu Wang et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2020)
Metabolism and epilepsy: Ketogenic diets as a homeostatic link
Susan A. Masino et al.
BRAIN RESEARCH (2019)
Synaptic energy metabolism and neuronal excitability, in sickness and health
Alfonso Oyarzabal et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2019)
Ketogenic Diet and Epilepsy: What We Know So Far
Isabella D'Andrea Meira et al.
FRONTIERS IN NEUROSCIENCE (2019)
Disordered breathing in a mouse model of Dravet syndrome
Fu-Shan Kuo et al.
ELIFE (2019)
The Efficacy of Ketogenic Diet in 60 Chinese Patients With Dravet Syndrome
Xiaojuan Tian et al.
FRONTIERS IN NEUROLOGY (2019)
The Biosynthesis, Signaling, and Neurological Functions of Bile Acids
Yoshimitsu Kiriyama et al.
BIOMOLECULES (2019)
Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation
Ana Ricobaraza et al.
SCIENTIFIC REPORTS (2019)
[18F]fluorodeoxyglucose positron-emission tomography study of genetically confirmed patients with Dravet syndrome
Kazuhiro Haginoya et al.
EPILEPSY RESEARCH (2018)
Evolution of Brain Glucose Metabolic Abnormalities in Children With Epilepsy and SCN1A Gene Variants
Ananyaa Kumar et al.
JOURNAL OF CHILD NEUROLOGY (2018)
Impairments in Oxidative Glucose Metabolism in Epilepsy and Metabolic Treatments Thereof
Tanya McDonald et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Bioenergetic Mechanisms of Seizure Control
Richard Kovacs et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology
Ingrid E. Scheffer et al.
EPILEPSIA (2017)
Plasma Membrane Na+-Coupled Citrate Transporter (SLC13A5) and Neonatal Epileptic Encephalopathy
Yangzom D. Bhutia et al.
MOLECULES (2017)
The mechanisms mediating the antiepileptic effects of the ketogenic diet, and potential opportunities for improvement with metabolism-altering drugs
Neil A. Youngson et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2017)
From genotype to phenotype in Dravet disease
Svetlana Gataullina et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2017)
Lactate Shuttles in Neuroenergetics - Homeostasis, Allostasis and Beyond
Shayne Mason
FRONTIERS IN NEUROSCIENCE (2017)
New insights into the mechanisms of the ketogenic diet
Detlev Boison
CURRENT OPINION IN NEUROLOGY (2017)
Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics
Patrycja Puchalska et al.
CELL METABOLISM (2017)
Alpha-Ketoglutarate: Physiological Functions and Applications
Nan Wu et al.
BIOMOLECULES & THERAPEUTICS (2016)
Effects of bile acids on neurological function and disease
Matthew McMillin et al.
FASEB JOURNAL (2016)
The interneuron energy hypothesis: Implications for brain disease
Oliver Kann
NEUROBIOLOGY OF DISEASE (2016)
Metabolic responses differentiate between interictal, ictal and persistent epileptiform activity in intact, immature hippocampus in vitro
Anton I. Ivanov et al.
NEUROBIOLOGY OF DISEASE (2015)
Targeting LDH enzymes with a stiripentol analog to treat epilepsy
Nagisa Sada et al.
SCIENCE (2015)
Epilepsy, energy deficiency and new therapeutic approaches including diet
Christopher A. Reid et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Preferential inactivation of Scn1a in parvalbumin interneurons increases seizure susceptibility
Stacey B. Dutton et al.
NEUROBIOLOGY OF DISEASE (2013)
Sugar for the brain: the role of glucose in physiological and pathological brain function
Philipp Mergenthaler et al.
TRENDS IN NEUROSCIENCES (2013)
Glucose transporter type I deficiency syndrome: Epilepsy phenotypes and outcomes
Amanda W. Pong et al.
EPILEPSIA (2012)
Norepinephrine: A Neuromodulator That Boosts the Function of Multiple Cell Types to Optimize CNS Performance
John O'Donnell et al.
NEUROCHEMICAL RESEARCH (2012)
Insights into pathophysiology and therapy from a mouse model of Dravet syndrome
John C. Oakley et al.
EPILEPSIA (2011)
Neuronal-Astrocyte Metabolic Interactions: Understanding the Transition Into Abnormal Astrocytoma Metabolism
Dennis A. Turner et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Mitochondrial dysfunction and oxidative stress: a contributing link to acquired epilepsy?
Simon Waldbaum et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2010)
beta-Alanine as a small molecule neurotransmitter
K. E. Tiedje et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
The ketogenic diet: Uses in epilepsy and other neurologic illnesses
Kristin W. Barañano et al.
Current Treatment Options in Neurology (2008)
Nav1.1 is predominantly expressed in nodes of Ranvier and axon initial segments
Amandine Duflocq et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2008)
Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy
Frank H. Yu et al.
NATURE NEUROSCIENCE (2006)
The role of norepinephrine in epilepsy: from the bench to the bedside
FS Giorgi et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2004)
Lactate:: A preferred fuel for human brain metabolism in vivo
D Smith et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2003)
A Cre/loxP-deleter transgenic line in mouse strain 129S1/SvImJ
SHE Tang et al.
GENESIS (2002)
Norepinephrine is required for the anticonvulsant effect of the ketogenic diet
P Szot et al.
DEVELOPMENTAL BRAIN RESEARCH (2001)